First lady Melania Trump welcomed a number of children of White House employees to The People's House on Tuesday afternoon.The "White House Take Our Daughters and Sons to Work Day" featured an array of activities scattered around the complex for children of all ages to take part in the fun.The first lady greeted children in the East Garden, assisting the kids with decorating American flags.FIRST LADY MELANIA TRUMP SCORES WIN FOR AMERICA'S FOSTER YOUTH WITH $25M INVESTMENTChildren drew on the wooden flags with red and blue markers.They also added star stickers as well as small and fluffy red, white, and bluepom-pomballs.The first lady was seen donning a white button-up blouse along with a floral pencil skirt.FIRST LADY MELANIA TRUMP UNVEILS NEW STAMP HONORING BARBARA BUSH: 'HER LEGACY LIVES ON'Many children were seen sporting "Gulf of America" Navy hats with "45-47" embroidered in red on the side.On Monday, President Donald Trump signed the Take it Down Act alongside the first lady, who has been championing the issue since her husbands inauguration.The bill punishes internet abuse involving nonconsensual and explicit imagery.For more Lifestyle articles, visit foxnews.com/lifestyleThe first lady also scored a big win for her "Be Best" initiative, securing a $25 million foster youth investment to be included in the presidents 2026 fiscal year budget.Mrs. Trump has been very active in hosting a variety of recent events at the White House.CLICK HERE TO SIGN UP FOR OUR LIFESTYLE NEWSLETTERAhead of Mothers Day, the first lady honored military moms by hosting moms serving the nation in uniform, the mothers of service members and mothers whose spouses serve in the U.S. Armed Forces.The first lady also paid tribute to the late Barbara Bush in a stamp dedication ceremony, hosting former Bush staffers along with family and friends.CLICK HERE TO SIGN UP FOR OUR LIFESTYLE NEWSLETTER"The unveiling of this commemorative stamp honors Barbara Bushs contributions asfirstladyand her enduring impact on our nation," Melania Trump said at the time.

The Phoenix Suns and Mercury fired back at an accusation in a recent lawsuit that claimed the franchises CEO Josh Bartelstein was having an affair with WNBA player Sophie Cunningham.The accusation surfaced in a lawsuit from former employee Gene Traylor against Suns Legacy Partners, LLC. The lawsuit was publicized last week, but one detail came to light during the week.CLICK HERE FOR MORE SPORTS COVERAGE ON FOXNEWS.COMTraylor said in the lawsuit he met with Josh Bartelstein, who is married, and told him that Cornelius Craig, the teams vice president of security of security and risk management, had been going around telling people that Bartelstein was having an affair with Cunningham."When Bartelstein asked Plaintiff to reveal what Craig was saying, Plaintiff explained that Craig had been telling others, Josh Bartelstein is f-----g Sophie Cunningham," the lawsuit filed in Arizona District Court read. "Additionally, Plaintiff requested that Bartelstein speak with the security team about Craigs behavior."The Suns responded in a statement to Fox News Digital."The recent reports concerning Josh Bartelstein and Sophie Cunningham are entirely false and morally reprehensible. Lets be absolutely clear about the origin of these claims," Suns senior vice president of communications Stacey Mitch said."Attorney Sheree Wright, a personal injury and immigration lawyer, currently serving a two year probation with the Arizona State Bar for violating the rules of professional conduct, sees an opportunity because of the reports about previous ownership. Ms. Wright has now filed four separate lawsuits against the organization, seeking over $140 million dollars in compensation. To date, her cases have been dismissed by the Equal Employment Opportunity Commission and Arizona Civil Rights Division or voluntarily withdrawn.CAITLIN CLARK SPEAKS OUT ON WNBA'S PROBE INTO ALLEGED 'HATEFUL COMMENTS' TOWARD ANGEL REESE"She continues to insert salacious lies and fabrications into her complaintsknowing that the media may report them as fact, as happened yesterdayshe hopes to coerce the Phoenix Suns into settling. Sheree Wright will not extort our organization and never see a single dollar."We will pursue all available legal avenues and hold those accountable for participating in the spread of misleading and false narratives."Wright is one of the attorneys representing Traylor in the case.Traylor, the teams former director of safety, security and risk management, filed a lawsuit against Suns Legacy Partners, LLC, accusing the company of discrimination, harassment and retaliation. He also alleged that the team retaliated against him after he reported weapons breaches.The Suns called the allegations Taylor made against the franchise "delusional and categorically false.""Guest safety is our top priority," a Suns spokeswoman told ESPN last week. "We continue to meet and exceed safety expectations. We regularly conduct security tests, which is standard across the industry. We have used these proactive measures to ensure we are operating at the highest level of safety and preparedness."Fox News Digital reached out to a Cunningham rep for comment.She was traded to the Fever from the Mercury in the offseason. She signed an extension with the Mercury before being traded and called Phoenix her "home away from home."Cunningham sat out of Saturdays game against the Chicago Sky with an ankle injury.Follow Fox News Digitalssports coverage on X and subscribe to the Fox News Sports Huddle newsletter.

Secretary of State Marco Rubio fired back at Sen. Chris Van Hollen after the Maryland Democrat said he regretted voting for Rubio as President Donald Trumps chief foreign affairs adviser, leading to a fiery exchange during a Senate hearing on Tuesday.Rubio testified before the Senate Foreign Relations Committee on the State Department's budget proposal when Van Hollen used his time to tear into the State Department for revoking visas of those found disrupting college campuses or committing acts of violence."Your campaign of fear and repression is eating away at the foundational values of our democracy," Van Hollen said, likening Rubio to the era of Sen. Joseph McCarthy. He added, "And I have to tell you directly and personally that I regret voting for you for Secretary of State.""First of all, your regret for voting for me confirms I'm doing a good job," Rubio replied.JUDGE ON WARPATH PRESSES TRUMP DOJ ON ABREGO GARCIA DEPORTATION, ANSWERS LEAVE COURTROOM IN STUNNED SILENCE"Thats just a flippant statement, Mr. Secretary," Van Hollen shot back.Committee Chairman Jim Risch, R-Idaho, interjected, asking Van Hollen to let Rubio respond to his claims without interruption. When Van Hollen asked if he can, in turn, respond to Rubio, Risch said, "Your time is up, Mr. Senator, and woefully used I might add."Rubio continued, saying that in the case of El Salvador, "we deported gang members including the one you had a margarita with," referencing Van Hollens visit to see deported "Maryland man" Kilmar Abrego Garcia in El Salvador. "And that guy is a human trafficker, and that guy is a gangbanger, and the evidence is going to be clear in the days to come."Van Hollen then jumped in, shouting to the chairman that Rubio "cant make unsubstantiated comments like that.""Secretary Rubio should take that testimony to the federal court of the United States because he hasnt done it under oath," Van Hollen said before Risch banged the gavel to allow Rubio to continue.TRUMP ADMINISTRATION BEGINS NEW WAVE OF INTERNATIONAL STUDENT VISA REVOCATIONS: NO ONE HAS A RIGHT TO A VISA'Rubio continued: "About the student visas, let me say this. I dont deport anybody and I dont snatch anybody. The State Department does not have officers in the streets snatching everybody. What I do is revoke visas. And its very simple. A visa is not a right. It is a privilege.""People apply for student visas to come into the United States and study. And if you tell me youre coming to the United States to lead campus crusades, to take over libraries, and try to burn down buildings and acts of violence, were not going to give you a visa," he continued.Van Hollen shot back that Rubio "was just blowing smoke here now."Rubio responded: "The bottom line is, if youre coming here to stir up trouble on our campuses, we will deny you a visa. And if you have a visa, and we find you, we will revoke it."Rubio said the Trump administration will continue to revoke the visas of those who are here as guests and are disrupting college campuses.A senior State Department official reacted to the exchange in a statement to Fox News Digital."Once again, Senator Van Hollen proves that he cares more about illegal immigrants than his own constituents," the senior State Department official said.

Welcome to the Fox News Entertainment Newsletter.TOP 3:- Mariska Hargitay reveals shocking family secret about her biological father- Dakota Johnson struggled to pay rent after father Don Johnson cut financial support- Former Playboy twins expose dark reality behind mansion's glamorous facade'GOOD TIME' - Alan Jackson retires from touring after 30 years on the road.'NOT HERE TO TESTIFY' - Diddy's former protg Aubrey O'Day confirms she won't testify at rapper's sex-trafficking trial.RED CARPET CLASH - Denzel Washington erupts after photographer appears to grab him on Cannes red carpet.DOGG BITES BACK - Snoop Dogg fires back at critics calling him a 'sellout' after Trump inauguration performance.MONEY, MONEY, MONEY - Diddy hires former DOJ expert to save assets from government seizure: Inside empire at stake.OUT OF THE DARKNESS - Alana Honey Boo Boo Thompson says she was Mama June's 'little moneymaker' during drug addiction.DRESS TO IMPRESS - Halle Berry and Heidi Klum shine despite new Cannes dress code banning nudity, 'excessively voluminous' looks.LIKE WHAT YOURE READING?CLICK HERE FOR MORE ENTERTAINMENT NEWSFOLLOW FOX NEWS ON SOCIAL MEDIAFacebookInstagramYouTubeX, formerly Twitter

President Donald Trump and Russian President Vladimir Putin discussed a possible prisoner swap involving nine Americans during their phone call this week, The Associated Press reported.Russian presidential adviser Yuri Ushakov, who previously served as Russian ambassador to the U.S., made the announcement after Trump and Putin spoke for two hours Monday.Putin and Trump talked about a Russia-U.S. prisoner exchange, which Ushakov said was "in the works" and envisioned Moscow and Washington releasing nine people each. He did not offer any other details.The State Department did not immediately respond Tuesday to a request for comment from Fox News Digital.TRUMP SAYS RUSSIA, UKRAINE TO START CEASEFIRE NEGOTIATIONS AFTER PUTIN CALLThe development comes following the release of Russian American Ksenia Karelina, who was freed from Russia in April after being detained for more than a year.TRUMP MEETS WITH FREED RUSSIAN AMERICAN WHO WAS DETAINED ABROAD FOR OVER A YEARBoth Trump and Putin described the call on Monday in a positive light, with the Kremlin chief saying it was "frank" and "useful," but it is not immediately clear what results were achieved. Trump took to social media to praise the call as having gone "very well" and said, "Russia and Ukraine will immediately start negotiations toward a Ceasefire and, more importantly, an END to the War."Putin, in a statement after the call, also noted that "a ceasefire with Ukraine is possible" but noted that "Russia and Ukraine must find compromises that suit both sides."Fox News Digitals Elizabeth Pritchett, Caitlin McFall and The Associated Press contributed to this report.

Joe Bidens recent diagnosis of "aggressive" prostate cancer has sparked concerns about how far the disease has advanced.The former presidents prostate cancer has been characterized by a Gleason score of 9 (grade group 5) with "metastasis to the bone."The score of 9 indicates "high-grade" prostate cancer with very abnormal cells that are likely to grow quickly, experts say.BIDEN'S PROSTATE CANCER DESCRIBED AS 'AGGRESSIVE' WHAT TO KNOW ABOUT THE DISEASE'S PROGNOSIS"While this represents a more aggressive form of the disease, the cancer appears to be hormone-sensitive, which allows for effective management," the statement said. "The president and his family are reviewing treatment options with his physicians."The fact that Bidens cancer has been classified as "hormone-sensitive" means it could be more responsive to hormone therapies, and thus more treatable.Hormone-sensitive prostate cancer needs androgens (male hormones) to grow, according to the National Cancer Institute. When those androgens are reduced or blocked, the cancer stops growing.Dr. Marc Siegel, clinical professor of medicine at NYU Langone Health and Fox News senior medical analyst, said the hormone-sensitive designation doesnt necessarily mean Biden has already been taking hormone therapies, which is unknown.GLEASON SCORE FOR PROSTATE CANCER: WHAT TO KNOW ABOUT BIDEN'S DIAGNOSIS"You can tell under a microscope if this is the type of cancer that could respond to hormone therapy, but no matter what it looks like, you dont know until you try it," he told Fox News Digital."And sometimes it looks like there will be an effect, but it ends up being resistant to therapy."Prostate cancer has long been known to feed on the male hormone testosterone, according to Dr. Bilal Siddiqui, M.D., a medical oncologist and prostate cancer researcher at The University of Texas MD Anderson Cancer Center."The overwhelming majority of prostate cancers 99% plus are hormone-sensitive and dependent on testosterone in the beginning," he told Fox News Digital."I would say its a very reasonable assumption [of hormone sensitivity], but we would know definitively once hormone therapy has started."The backbone of treatment for any metastatic prostate cancer is "androgen deprivation therapy," which is geared toward decreasing the body's level of testosterone."Typically, when you start the androgen deprivation therapy, testosterone levels will decrease and the PSA levels will decrease along with it, and that's your definitive proof that the cancer is hormone-sensitive," Siddiqui said.Historically, androgen (hormone) deprivation therapy was done surgically through removal of the testes but todays typical methods include pills or injections, according to the oncologist."That eliminates about 80 to 85% of the testosterone that's produced in the body," he said.In many cases, doctors may add other drugs to block testosterone from secondary sources in the body, such as the adrenal glands that sit above the kidneys.NEW PROSTATE CANCER TEST PINPOINTS DISEASE BETTER THAN PSA OPTION, STUDY FINDSNorth Carolina family physician Dr. Alexa Mieses Malchuk reiterated that prostate cancer that shrinks or slows in progression after blocking testosterone qualifies as hormone-sensitive."This means that it grows or shrinks in relation to how much androgen or testosterone is circulating in the body," she told Fox News Digital."If you suppress testosterone and the cancer does not shrink and continues to grow or spread, then the cancer is independent of the amount of hormone circulating in the body."There are a number of different ways to monitor disease progression, but its most commonly done by a combination of PSA blood tests and imaging studies, the doctor noted.Eventually, metastatic prostate cancer will progress to become hormone-resistant, which means it no longer responds to hormone therapy, according to Siddiqui."It can vary in how long it takes to get to that point," the oncologist said. "It's usually a couple of years before it evolves from hormone-sensitive to hormone-resistant."The "ultimate test" of whether cancer has become hormone-resistant is to lower testosterone levels and observe where the cancer goes, he noted.There may also signs of the disease getting worse."That might mean a rising PSA (prostate-specific antigen) test, new pain or symptoms, or new tumors that show up on the scan," Siddiqui told Fox News Digital.CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTERThe U.S. Preventive Services Task Force states that men aged 55 to 69 years should have the option to undergo periodic prostate-specific antigen (PSA)-based screening to monitor for prostate cancer."Before deciding whether to be screened, men should have an opportunity to discuss the potential benefits and harms of screening with their clinician and to incorporate their values and preferences in the decision," the USPSTF states.Siegel questioned this guidance to skip screening for older men.For more Health articles, visitwww.foxnews.com/health"I dont agree with guidelines to not test over 70 years of age, especially with so many treatments to offer for prostate cancer," he said.In addition to hormone therapy, some men may be candidates for robotic prostate surgery, chemotherapy and radiation, Siegel added.

Joe Bidens recent diagnosis of "aggressive" prostate cancer has sparked concerns about how far the disease has advanced.The former presidents prostate cancer has been characterized by a Gleason score of 9 (grade group 5) with "metastasis to the bone."The score of 9 indicates "high-grade" prostate cancer with very abnormal cells that are likely to grow quickly, experts say.BIDEN'S PROSTATE CANCER DESCRIBED AS 'AGGRESSIVE' WHAT TO KNOW ABOUT THE DISEASE'S PROGNOSIS"While this represents a more aggressive form of the disease, the cancer appears to be hormone-sensitive, which allows for effective management," the statement said. "The president and his family are reviewing treatment options with his physicians."The fact that Bidens cancer has been classified as "hormone-sensitive" means it could be more responsive to hormone therapies, and thus more treatable.Hormone-sensitive prostate cancer needs androgens (male hormones) to grow, according to the National Cancer Institute. When those androgens are reduced or blocked, the cancer stops growing.Dr. Marc Siegel, clinical professor of medicine at NYU Langone Health and Fox News senior medical analyst, said the hormone-sensitive designation doesnt necessarily mean Biden has already been taking hormone therapies, which is unknown.GLEASON SCORE FOR PROSTATE CANCER: WHAT TO KNOW ABOUT BIDEN'S DIAGNOSIS"You can tell under a microscope if this is the type of cancer that could respond to hormone therapy, but no matter what it looks like, you dont know until you try it," he told Fox News Digital."And sometimes it looks like there will be an effect, but it ends up being resistant to therapy."Prostate cancer has long been known to feed on the male hormone testosterone, according to Dr. Bilal Siddiqui, M.D., a medical oncologist and prostate cancer researcher at The University of Texas MD Anderson Cancer Center."The overwhelming majority of prostate cancers 99% plus are hormone-sensitive and dependent on testosterone in the beginning," he told Fox News Digital."I would say its a very reasonable assumption [of hormone sensitivity], but we would know definitively once hormone therapy has started."The backbone of treatment for any metastatic prostate cancer is "androgen deprivation therapy," which is geared toward decreasing the body's level of testosterone."Typically, when you start the androgen deprivation therapy, testosterone levels will decrease and the PSA levels will decrease along with it, and that's your definitive proof that the cancer is hormone-sensitive," Siddiqui said.Historically, androgen (hormone) deprivation therapy was done surgically through removal of the testes but todays typical methods include pills or injections, according to the oncologist."That eliminates about 80 to 85% of the testosterone that's produced in the body," he said.In many cases, doctors may add other drugs to block testosterone from secondary sources in the body, such as the adrenal glands that sit above the kidneys.NEW PROSTATE CANCER TEST PINPOINTS DISEASE BETTER THAN PSA OPTION, STUDY FINDSNorth Carolina family physician Dr. Alexa Mieses Malchuk reiterated that prostate cancer that shrinks or slows in progression after blocking testosterone qualifies as hormone-sensitive."This means that it grows or shrinks in relation to how much androgen or testosterone is circulating in the body," she told Fox News Digital."If you suppress testosterone and the cancer does not shrink and continues to grow or spread, then the cancer is independent of the amount of hormone circulating in the body."There are a number of different ways to monitor disease progression, but its most commonly done by a combination of PSA blood tests and imaging studies, the doctor noted.Eventually, metastatic prostate cancer will progress to become hormone-resistant, which means it no longer responds to hormone therapy, according to Siddiqui."It can vary in how long it takes to get to that point," the oncologist said. "It's usually a couple of years before it evolves from hormone-sensitive to hormone-resistant."The "ultimate test" of whether cancer has become hormone-resistant is to lower testosterone levels and observe where the cancer goes, he noted.There may also signs of the disease getting worse."That might mean a rising PSA (prostate-specific antigen) test, new pain or symptoms, or new tumors that show up on the scan," Siddiqui told Fox News Digital.CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTERThe U.S. Preventive Services Task Force states that men aged 55 to 69 years should have the option to undergo periodic prostate-specific antigen (PSA)-based screening to monitor for prostate cancer."Before deciding whether to be screened, men should have an opportunity to discuss the potential benefits and harms of screening with their clinician and to incorporate their values and preferences in the decision," the USPSTF states.Siegel questioned this guidance to skip screening for older men.For more Health articles, visitwww.foxnews.com/health"I dont agree with guidelines to not test over 70 years of age, especially with so many treatments to offer for prostate cancer," he said.In addition to hormone therapy, some men may be candidates for robotic prostate surgery, chemotherapy and radiation, Siegel added.

Joe Bidens recent diagnosis of "aggressive" prostate cancer has sparked concerns about how far the disease has advanced.The former presidents prostate cancer has been characterized by a Gleason score of 9 (grade group 5) with "metastasis to the bone."The score of 9 indicates "high-grade" prostate cancer with very abnormal cells that are likely to grow quickly, experts say.BIDEN'S PROSTATE CANCER DESCRIBED AS 'AGGRESSIVE' WHAT TO KNOW ABOUT THE DISEASE'S PROGNOSIS"While this represents a more aggressive form of the disease, the cancer appears to be hormone-sensitive, which allows for effective management," the statement said. "The president and his family are reviewing treatment options with his physicians."The fact that Bidens cancer has been classified as "hormone-sensitive" means it could be more responsive to hormone therapies, and thus more treatable.Hormone-sensitive prostate cancer needs androgens (male hormones) to grow, according to the National Cancer Institute. When those androgens are reduced or blocked, the cancer stops growing.Dr. Marc Siegel, clinical professor of medicine at NYU Langone Health and Fox News senior medical analyst, said the hormone-sensitive designation doesnt necessarily mean Biden has already been taking hormone therapies, which is unknown.GLEASON SCORE FOR PROSTATE CANCER: WHAT TO KNOW ABOUT BIDEN'S DIAGNOSIS"You can tell under a microscope if this is the type of cancer that could respond to hormone therapy, but no matter what it looks like, you dont know until you try it," he told Fox News Digital."And sometimes it looks like there will be an effect, but it ends up being resistant to therapy."Prostate cancer has long been known to feed on the male hormone testosterone, according to Dr. Bilal Siddiqui, M.D., a medical oncologist and prostate cancer researcher at The University of Texas MD Anderson Cancer Center."The overwhelming majority of prostate cancers 99% plus are hormone-sensitive and dependent on testosterone in the beginning," he told Fox News Digital."I would say its a very reasonable assumption [of hormone sensitivity], but we would know definitively once hormone therapy has started."The backbone of treatment for any metastatic prostate cancer is "androgen deprivation therapy," which is geared toward decreasing the body's level of testosterone."Typically, when you start the androgen deprivation therapy, testosterone levels will decrease and the PSA levels will decrease along with it, and that's your definitive proof that the cancer is hormone-sensitive," Siddiqui said.Historically, androgen (hormone) deprivation therapy was done surgically through removal of the testes but todays typical methods include pills or injections, according to the oncologist."That eliminates about 80 to 85% of the testosterone that's produced in the body," he said.In many cases, doctors may add other drugs to block testosterone from secondary sources in the body, such as the adrenal glands that sit above the kidneys.NEW PROSTATE CANCER TEST PINPOINTS DISEASE BETTER THAN PSA OPTION, STUDY FINDSNorth Carolina family physician Dr. Alexa Mieses Malchuk reiterated that prostate cancer that shrinks or slows in progression after blocking testosterone qualifies as hormone-sensitive."This means that it grows or shrinks in relation to how much androgen or testosterone is circulating in the body," she told Fox News Digital."If you suppress testosterone and the cancer does not shrink and continues to grow or spread, then the cancer is independent of the amount of hormone circulating in the body."There are a number of different ways to monitor disease progression, but its most commonly done by a combination of PSA blood tests and imaging studies, the doctor noted.Eventually, metastatic prostate cancer will progress to become hormone-resistant, which means it no longer responds to hormone therapy, according to Siddiqui."It can vary in how long it takes to get to that point," the oncologist said. "It's usually a couple of years before it evolves from hormone-sensitive to hormone-resistant."The "ultimate test" of whether cancer has become hormone-resistant is to lower testosterone levels and observe where the cancer goes, he noted.There may also signs of the disease getting worse."That might mean a rising PSA (prostate-specific antigen) test, new pain or symptoms, or new tumors that show up on the scan," Siddiqui told Fox News Digital.CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTERThe U.S. Preventive Services Task Force states that men aged 55 to 69 years should have the option to undergo periodic prostate-specific antigen (PSA)-based screening to monitor for prostate cancer."Before deciding whether to be screened, men should have an opportunity to discuss the potential benefits and harms of screening with their clinician and to incorporate their values and preferences in the decision," the USPSTF states.Siegel questioned this guidance to skip screening for older men.For more Health articles, visitwww.foxnews.com/health"I dont agree with guidelines to not test over 70 years of age, especially with so many treatments to offer for prostate cancer," he said.In addition to hormone therapy, some men may be candidates for robotic prostate surgery, chemotherapy and radiation, Siegel added.

Acting Columbia University President Claire Shipman was interrupted by Free Mahmoud chants during a commencement speech Tuesday. (Video: Columbia University)

Fox News chief national security correspondent Jennifer Griffin has the latest on President Donald Trump's upcoming Golden Dome-related announcement on 'America Reports.'